DK2760466T3 - In-vivo-syntese af elastisk fiber - Google Patents

In-vivo-syntese af elastisk fiber Download PDF

Info

Publication number
DK2760466T3
DK2760466T3 DK12835454.5T DK12835454T DK2760466T3 DK 2760466 T3 DK2760466 T3 DK 2760466T3 DK 12835454 T DK12835454 T DK 12835454T DK 2760466 T3 DK2760466 T3 DK 2760466T3
Authority
DK
Denmark
Prior art keywords
elastic fiber
vivo synthesis
vivo
synthesis
fiber
Prior art date
Application number
DK12835454.5T
Other languages
English (en)
Inventor
Suzanne Marie Mithieux
Anthony Steven Weiss
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011904041A external-priority patent/AU2011904041A0/en
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Application granted granted Critical
Publication of DK2760466T3 publication Critical patent/DK2760466T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)
  • Medicinal Preparation (AREA)
DK12835454.5T 2011-09-30 2012-09-27 In-vivo-syntese af elastisk fiber DK2760466T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2011904041A AU2011904041A0 (en) 2011-09-30 In vivo synthesis of elastic fibre
PCT/AU2012/001179 WO2013044314A1 (en) 2011-09-30 2012-09-27 In vivo synthesis of elastic fiber

Publications (1)

Publication Number Publication Date
DK2760466T3 true DK2760466T3 (da) 2019-06-17

Family

ID=47994030

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19155435.1T DK3505180T3 (da) 2011-09-30 2012-09-27 In vivo-syntese af elastisk fiber
DK12835454.5T DK2760466T3 (da) 2011-09-30 2012-09-27 In-vivo-syntese af elastisk fiber

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19155435.1T DK3505180T3 (da) 2011-09-30 2012-09-27 In vivo-syntese af elastisk fiber

Country Status (15)

Country Link
US (5) US20140235547A1 (da)
EP (3) EP4088734A1 (da)
JP (1) JP6231004B2 (da)
KR (4) KR20190040373A (da)
CN (2) CN103841990A (da)
AU (4) AU2012315489B2 (da)
BR (1) BR112014007451A2 (da)
CA (1) CA2850384C (da)
DK (2) DK3505180T3 (da)
ES (2) ES2928997T3 (da)
HU (2) HUE044367T2 (da)
MX (2) MX361602B (da)
RU (3) RU2727510C2 (da)
TR (1) TR201905884T4 (da)
WO (1) WO2013044314A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10980865B2 (en) 2012-08-10 2021-04-20 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) * 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани
JP6694381B2 (ja) * 2013-09-24 2020-05-13 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ タンパク質抽出方法
TWI716365B (zh) * 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 注射型真皮填充劑組合物及其套組、製備方法、與使用
BR112019008509A2 (pt) * 2016-11-04 2019-07-09 Allergan Pharmaceuticals Int Ltd dispositivos biossintéticos
US20190275087A1 (en) * 2018-03-01 2019-09-12 Allergan Pharmaceuticals International Limited Expansion and differentiation of stem cells
AU2020270005A1 (en) * 2019-05-03 2022-01-06 Allergan Pharmaceuticals International Limited Scar prevention and/or treatment
CA3152006A1 (en) * 2019-08-23 2021-03-04 Allergan Pharmaceuticals International Limited Tropoelastin for use in treatment of acne scarring
EP4149578A1 (en) * 2020-05-14 2023-03-22 Allergan Pharmaceuticals International Limited Compositions comprising tropoelastin crosslinked to hyaluronic acid and methods of use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3474190B2 (ja) 1992-12-22 2003-12-08 ザ ユニバーシテイ オブ シドニイ 合成ポリヌクレオチド
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6000849A (en) 1998-06-26 1999-12-14 3M Innovative Properties Company Gift package
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
FR2801307B1 (fr) * 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
RU2194512C1 (ru) * 2001-12-18 2002-12-20 Закрытое акционерное общество "Академия научной красоты" Способ профилактики и коррекции процесса старения кожи
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
RU2281082C1 (ru) * 2005-01-28 2006-08-10 Элина Юрьевна Соловьева Способ коррекции эстетических и возрастных проблем кожи
RU2338562C2 (ru) * 2006-03-10 2008-11-20 Государственное учреждение Научный центр медицинской экологии Восточно-Сибирского научного центра Сибирского отделения Российской Академии медицинских наук (ГУ НЦ МЭ ВСНЦ СО РАМН) Способ лечения кожных стрий
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
FR2920968B1 (fr) * 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
FR2926997B1 (fr) * 2008-02-04 2012-06-29 Bernard Hertzog Aiguilles souples fines pour injection sous cutanee sans douleur
WO2009128584A1 (en) * 2008-04-14 2009-10-22 C.A. Pharm Co., Ltd. The composition for the prevention and treatment of striae distensae and atopy
US8080265B2 (en) * 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
WO2010102337A1 (en) * 2009-03-10 2010-09-16 The University Of Sydney Injectable biomaterials
EP4062950A1 (en) * 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
US9611312B2 (en) * 2010-11-23 2017-04-04 Elastagen Pty. Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
TWI583359B (zh) 2013-02-22 2017-05-21 巴科納 包瑞斯 Ｄｓ 預防骨質流失之骨內牙植體及基牙

Also Published As

Publication number Publication date
KR20220049614A (ko) 2022-04-21
KR102387297B1 (ko) 2022-04-15
US20250325638A1 (en) 2025-10-23
AU2012315489A1 (en) 2014-04-10
US20190328845A1 (en) 2019-10-31
CN103841990A (zh) 2014-06-04
JP2014527988A (ja) 2014-10-23
AU2019204915B2 (en) 2020-04-16
AU2020204197B2 (en) 2022-03-17
EP3505180B1 (en) 2022-08-03
EP2760466A4 (en) 2015-05-27
DK3505180T3 (da) 2022-09-19
MX2014003702A (es) 2015-08-13
EP3505180A1 (en) 2019-07-03
AU2017204582B2 (en) 2019-04-11
EP4088734A1 (en) 2022-11-16
ES2729285T3 (es) 2019-10-31
TR201905884T4 (tr) 2019-05-21
CN107252478A (zh) 2017-10-17
RU2016139716A3 (da) 2020-01-27
US20240000898A1 (en) 2024-01-04
RU2020121715A (ru) 2021-12-30
RU2016139716A (ru) 2018-12-14
KR20190040373A (ko) 2019-04-17
HUE044367T2 (hu) 2019-10-28
MX361602B (es) 2018-12-10
CA2850384A1 (en) 2013-04-04
RU2602861C2 (ru) 2016-11-20
KR20140084059A (ko) 2014-07-04
KR20200060783A (ko) 2020-06-01
ES2928997T3 (es) 2022-11-24
AU2017204582A1 (en) 2017-07-27
KR102527367B1 (ko) 2023-04-28
MX2018015349A (es) 2021-06-15
JP6231004B2 (ja) 2017-11-15
AU2020204197A1 (en) 2020-07-16
KR101969104B1 (ko) 2019-04-15
HUE060291T2 (hu) 2023-02-28
CA2850384C (en) 2023-08-15
EP2760466A1 (en) 2014-08-06
RU2014114649A (ru) 2015-11-10
WO2013044314A1 (en) 2013-04-04
AU2012315489B2 (en) 2017-04-06
AU2019204915A1 (en) 2019-07-25
US20230121324A1 (en) 2023-04-20
US20140235547A1 (en) 2014-08-21
BR112014007451A2 (pt) 2017-04-04
EP2760466B1 (en) 2019-03-20
RU2727510C2 (ru) 2020-07-22

Similar Documents

Publication Publication Date Title
HUS1900001I1 (hu) Transztiretin expressziójának módosítása
DK3235812T3 (da) Deutererede derivater af ivacaftor
SMT201400058B (it) Produzione stabile di vettori lentivirali
BR112014003878A2 (pt) síntese de r-bifenilalaninol
PT2604625T (pt) Geração de moléculas de ligação
DK2482106T5 (da) Multimode-fiber
DK3725778T4 (da) Formuleringer af enzalutamid
DK2603232T3 (da) Stabile formuleringer af linaclotid
UY4115Q (es) Reloj
DK3505180T3 (da) In vivo-syntese af elastisk fiber
EP2628435A4 (en) insertion
DK2733803T4 (da) Sektion af kabelbakke
EP2687876A4 (en) LENS ARRANGEMENT
DK2529044T3 (da) Smelteblæst fiber
CR20140310A (es) Agentes de reversión anticoagulante
DK2936306T3 (da) Generering af en brugertilpasset anvendelse
EP2714975A4 (en) ELASTIC FABRIC
EP2691361A4 (en) SYNTHESIS OF DIAZIDEN
BR112013019929A2 (pt) fibra óptica
DK2748584T3 (da) Parallelle optiske undersøgelser af en prøve
DK2731572T3 (da) Forbedringer af indgivelsesanordninger
EP2714920A4 (en) CLOZAPINIMMUNOASSAY
DK2838850T3 (da) Oprensning af titantetrachlorid
DK2407155T3 (da) Formuleringer af inecalcitol
DK2731573T3 (da) Forbedringer af indgivelsesanordninger